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Abstract
Stem cell factor (SCF) is a hematopoietic growth factor that exerts its activity by signalling through the tyrosine kinase
receptor known as Kit or CD117. SCF-Kit signalling is crucial for the survival, proliferation and differentiation of
hematopoietic cells of myeloid lineage. Furthermore, since myeloid leukaemia cells express the Kit receptor, SCF may play
an important role in myeloid leukaemia progression too. However, the mechanisms of this pathophysiological effect remain
unclear. Recent evidence shows that SCF triggers accumulation of the inducible alpha subunit of hypoxia-inducible factor 1
(HIF-1) in hematopoietic cells—a transcription complex that plays a pivotal role in cellular adaptation to low oxygen
availability. However, it is unknown how SCF impacts on HIF-1a accumulation in human myeloid leukaemia and mast cells.
Here we show that SCF induces HIF-1a accumulation in THP-1 human myeloid leukaemia cells but not in LAD2 mast cells.
We demonstrated that LAD2 cells have a more robust glutathione (GSH)-dependent antioxidative system compared to THP-
1 cells and are therefore protected against the actions of ROS generated in an SCF-dependent manner. BSO-induced GSH
depletion led to a significant decrease in HIF-1a prolyl hydroxylase (PHD) activity in THP-1 cells and to near attenuation of it
in LAD2 cells. In THP-1 cells, SCF-induced HIF-1a accumulation is controlled via ERK, PI3 kinase/PKC-d/mTOR-dependent and
to a certain extent by redox-dependent mechanisms. These results demonstrate for the first time an important cross-talk of
signalling pathways associated with HIF-1 activation—an important stage of the myeloid leukaemia cell life cycle.
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Introduction
Stem cell factor (SCF) is a cytokine that plays a crucial role in
hematopoiesis and melanogenesis [1]. It is recognised by the Kit
receptor, also known as CD117 [1,2], which is expressed in
different types of non-differentiated hematopoietic cells including
myeloblasts and pro-monoblasts [1]. Importantly, human myeloid
leukaemia cells express the Kit receptor and their proliferation is
upregulated by SCF [1-3], although mast cells are the only
terminally differentiated hematopoietic cells that continue to
express Kit [1,3,4].
In myeloid leukaemia cells SCF triggers accumulation of
hypoxia-inducible factor 1 alpha (HIF-1a), an inducible subunit
of the HIF-1 transcription complex [5]. HIF-1 is a heterodimeric
protein containing a constitutive beta and an inducible alpha
subunit. This complex plays a pivotal role in cellular adaptation to
low oxygen availability as well as to the inflammatory stress
associated with innate immune responses or allergic reactions [6].
The exact mechanisms leading to SCF-induced HIF-1a accumu-
lation in myeloid leukaemia cells are unknown. However, it has
been reported that mitogen-activated protein (MAP) and extra-
cellular signal-regulating kinase (ERK) kinase (MEK) as well as
phosphoinositide 3-kinase (PI3 kinase) but not p38 MAP kinase,
play a role in SCF-induced HIF-1a accumulation in human
myeloid leukaemia cells [5].
Since SCF acts via MEK, PI3 kinase and possibly protein kinase
C (PKC) a/b isoforms [5,7], one could hypothesise that SCF as
such impacts on the activation of NADPH oxidase leading to the
generation of reactive oxygen species (ROS) [6]. This assumption
is supported by the fact that ROS seem to mediate some of the
SCF-induced effects (e.g. glucose transport, synergy with granu-
locyte/macrophage colony-stimulating factor) [8,9]. PKC a/b are
known to activate NADPH oxidase by phosphorylating its
component p47phox [10,11]. These events trigger HIF-1a accumu-
lation, in most cases by affecting HIF-1a degrading prolyl-
hydroxylases (PHDs) [6,10,12,13]. However, mast cells, which are
cultured in the presence of SCF and require this factor for support
of their life cycle [14], do not suffer from permanent oxidative
stress. One could suggest that the quantity of ROS produced by
Kit-expressing cells in response to SCF is controlled by the
glutathione-dependent anti-oxidative system. This includes c-glu-
cys-gly tripeptide known as glutathione (GSH) and several
enzymes which produce GSH and which use it to scavenge
ROS (glutathione peroxidase, GPx, which reduces peroxides using
GSH as the electron/proton donor thus oxidising it to GSSG) and
to reduce GSH, thus re-generating its antioxidative activity
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antioxidative system in myeloid leukaemia cells and mast cells is,
however, unknown and it is unclear whether this system and
redox-dependent mechanisms in general play a role in SCF-
induced HIF-1a accumulation.
Here, we studied the mechanisms of SCF-induced HIF-1a
accumulation in THP-1 human myeloid cells. The key SCF-
induced effects observed were compared to those in LAD2 human
mast cells (which are normally cultured in the presence of SCF)
upon normal presence or withdrawal of SCF. We report that SCF
affects the GSH antioxidative system in THP-1 human myeloid
leukaemia cells while inducing HIF-1a accumulation and a
moderate increase in thiobarbiturate-reactive species (TBRS).
SCF-induced HIF-1a accumulation was found to be a concentra-
tion-dependent process in THP-1 cells. Conversely, withdrawal of
SCF did not significantly impact constitutive HIF-1a accumula-
tion observed in LAD2 mast cells, although these cells expressed
substantially higher amounts of GSH compared to those observed
in THP-1 cells. No significant changes in TBRS were observed in
LAD2 cells. The presence of SCF resulted in a very moderate
decrease in HIF-1a PHD activity in both THP-1 and LAD2 cells.
BSO-induced GSH depletion significantly decreased PHD activity
in THP-1 cells and nearly attenuated it in LAD2 mast cells,
suggesting an important protective function of GSH in both cell
types, especially in mast cells. Further experiments have showed
the role of PI3 kinase, ERK, PKC a, b and d isoforms as well as
mammalian target of rapamycin (mTOR) in HIF-1a stabilisation
in THP-1 cells. On the other hand, NADPH oxidase-dependent
ROS production was also found to contribute to the process to
certain extent.
Results
SCF induces HIF-1a accumulation and affects the GSH
antioxidative system in human myeloid leukaemia THP-1
cells but not in LAD2 mast cells
Firstly, we established whether SCF is able to induce HIF-1a
accumulation and, at the same time, affects the GSH-dependent
antioxidative system in THP-1 human myeloid leukaemia cells.
We observed that SCF significantly upregulated HIF-1a accumu-
lation in THP-1 cells following exposure to 100 ng/ml SCF for
24 h (Figure 1A). THP-1 cells also responded by a decrease in
GSH production and a reduced GSH/GSSG ratio (Figure 1A).
The presence of SCF reduced GPx activity, while no significant
changes were observed in GR activity. TBRS levels were modera-
tely increased in the presence of SCF (Figure 1A). Analysis of HIF-
1 DNA-binding activity showed that the protein is transcription-
ally active and significantly increased by 24 h incubation of THP-
1 cells with SCF (Figure 1B). Furthermore, we observed that this
SCF-mediated increase in HIF-1a accumulation was concentra-
tion dependent (Figure 1C).
Given the SCF-dependent effects on HIF-1a in THP-1 cells,
which are a partially differentiated cell line, we wished to elucidate
whether there is an overarching principle of SCF-mediated HIF-
1a accumulation in terminally differentiated hematopoietic cells of
myeloid lineage that still express functional Kit receptor. The only
example of the latter is the mast cell. We therefore used LAD2
human mast cells, which display essential human mast cell
properties [14]. These cells are normally cultured in the presence
of SCF, thus excluding the possibility of direct comparisons to
THP-1 cells. Despite this, however, we were able to determine
whether withdrawal of SCF from the culture media could lead to
downregulation of HIF-1a accumulation and associated effects in
these cells. We therefore reserved one fraction of LAD2 cells that
had been continuously cultured in the presence of 100 ng/ml SCF
and incubated with fresh (SCF-containing) media for 24 h, while
another fraction of these cells was cultured in SCF-free media for
24 h. In these settings, we were able to observe that SCF
withdrawal for 24 h resulted in only a weak, and not significant,
reduction in HIF-1a expression in LAD2 cells compared to those
incubated with SCF (Figure 2A), although constitutive HIF-1a
expressions in LAD2 cells cultured in the absence of SCF were
higher than previously observed in THP-1 cells. In contrast to our
previous data using THP-1 cells, LAD2 cells incubated in the
presence of SCF showed increased GSH production compared to
those cultured for 24 h without the cytokine (Figure 2A). The
presence of SCF also led to reduced GPx activity, while no
significant changes were observed in the activity of GR. TBRS
level remained unchanged in LAD2 cells independently of SCF
availability (Figure 2A). HIF-1 in LAD2 cells showed clear DNA-
binding activity, which was not significantly changed upon SCF
withdrawal (Figure 2B). Importantly, withdrawal of SCF neither
affected LAD2 mast cell viability nor their capacity to generate
vascular endothelial growth factor (VEGF; a HIF-1 downstream
gene) as measured by ELISA (data not shown).
GSH depletion leads to a significant decrease in HIF-1a
PHD activity in both THP-1 and LAD2 cells
Since ROS are likely to be produced in response to treatment
with SCF [8,9], we therefore investigated the role of the GSH-
dependent antioxidative system in both THP-1 and LAD2 cells.
THP-1 cells were stimulated for 24 h with 100 ng/ml SCF in the
absence or presence of 500 mM buthionine sulphoximine (BSO)
for 24 h. For control purposes, SCF-untreated cells also were
exposed to 500 mM BSO for 24 h. We observed that, in THP-1
cells, the presence of BSO but in the absence of SCF led to
decreased HIF-1a PHD activity (Figure 3A). In the presence of
SCF, BSO also reduced PHD activity in THP-1 cells (Figure 3A).
In parallel, HIF-1a accumulation in THP-1 cells was decreased by
BSO in the absence of SCF. However, following 24 h exposure to
SCF, HIF-1a accumulation was not affected by this inhibitor. The
number of cells stainable with annexin V was significantly higher
compared to the number of DAPI stainable cells in cells exposed to
BSO independently of the presence or absence of SCF (Figure 3B).
We also compared the effects of BSO in LAD2 cells. For this
purpose, we incubated one fraction of LAD2 cells in fresh media
containing 100 ng/ml SCF and another fraction in fresh SCF-free
media for 24 h. Both aliquots were incubated either with or
without 500 mM BSO during this 24 h period. In the presence of
SCF, BSO strikingly inhibited PHD activity (Figure 4A). HIF-1a
accumulation in LAD2 cells was decreased in the presence of BSO
in cells where SCF had been withdrawn. HIF-1a accumulation in
cells exposed to SCF was not affected by BSO. As with THP-1
cells, the number of LAD2 cells stainable with annexin V was
significantly higher compared to the number of DAPI stainable
cells upon exposure to BSO independently of the presence/
absence of SCF (Figure 4B).
This suggests that the cells begin to employ a PHD-dependent
mechanism of HIF-1a accumulation in cases where GSH levels
are affected. It may, however, also mean that GSH depletion
chemically affects PHD activity by causing oxidation of PHD Fe
2+,
thus reducing its ability to hydroxylate HIF-1a [6,13]. Decreased
HIF-1a levels in cells exposed to BSO in the absence of SCF are
probably controlled by apoptosis-dependent inactivation of some
of the cells. Apoptotic changes might be caused by GSH depletion
– this could be seen in the results of annexin V/DAPI staining
presented in the Figures 3B and 4B.
Stem Cell Factor Induces HIF-1 Activation
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regulated by several signalling pathways
Since SCF was found to induce HIF-1a accumulation in THP-1
but not LAD2 cells, we investigated the biochemical mechanisms
behindthisprocess.Westudied the contributionofseveralsignalling
pathways including ERK, phospholipase C 1 gamma (PLC-1c the
enzyme which is one of the upstream regulators of PKC a/b [8,10])
and PI3 kinase. We also investigated the involvement of PKC a/b-
induced NADPH oxidase activation leading to the generation of
ROS. We first pre-treated THP-1 cells for 1 h with 10 mM
PD098059 (ERK inhibitor) [12], 30 mM U73122 (PLC-1c
inhibitor), 30 mM LY294002 (PI3 kinase inhibitor), 70 nM
Go ¨6983 (PKC a/b inhibitor), 30 mM DPI (NADPH oxidase
inhibitor) and 1 mM NAC (ROS scavenging antioxidant, which
also leads to an increase in intracellular GSH levels) [10,12,16,17].
Cells were then exposed for 4 h to 100 ng/ml SCF. HIF-1a
accumulation and production of VEGF (a HIF-1 downstream gene)
were then analysed. We observed that PD098059 and LY294002
but not U73122 attenuated both SCF-induced HIF-1a accumula-
tion and VEGF release (Figure 5). Go ¨6983, DPI and NAC
downregulated both HIF-1a accumulation and VEGF production
in THP-1 cells (Figure 5). One could therefore hypothesise that PI3
kinase, ERK and, to some extent, ROS, generated in a PKC a/b -
NADPH oxidase-dependent manner contribute to SCF-induced
HIF-1a accumulation in THP-1 cells, while PLC-1c does not seem
to participate. Given these results, we were interested to see whether
apoptosis signal-regulating kinase 1 (ASK1), the ROS dependent
pro-apoptotic upstream MAP kinase kinase kinase, could be
involved in SCF-induced HIF-1a accumulation in THP-1 cells
since Toll-like receptor 4-mediated processes are associated with
Figure 1. The impact of SCF on HIF-1a accumulation and the GSH-dependent antioxidative system in human myeloid leukaemia
cells. (A) THP-1 human myeloid leukaemia cells were stimulated for 24 h with 100 ng/ml SCF. HIF-1a accumulation, GSH and GSSG levels, GPx/GR
activities and the quantity of the TBRS were then measured as outlined in Materials and methods. (B) THP-1 human myeloid leukaemia cells were
cultured in the presence or absence of 100 ng/ml SCF for 24 h. HIF-1 DNA-binding activity was analysed using 10 mg/ml BSA as a negative control.
(C) THP-1 cells were exposed for 4 h to 25, 50 and 100 ng/ml SCF. HIF-1a accumulation was then measured as described in Materials and methods.
Quantitative data are mean values 6 S.D. of at least three individual experiments. *P,0.01 vs control. Western blot data are shown from one
representative experiment out of three that gave similar results.
doi:10.1371/journal.pone.0022502.g001
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hours of exposure of THP-1 cells, transfected with the dominant-
negative ASK1 isoform, to 100 ng/ml SCF led to further non-
significant increases in HIF-1a accumulation supported by
increased VEGF production (albeit not significant). We were also
interested to see whether other reactive species-generating enzymes,
which are normally upregulated in a cytokine–dependent manner,
contribute to SCF-induced HIF-1a accumulation. These included
xanthine oxidase (XOD, which converts hypoxanthine into
xanthine and further into uric acid and produces superoxide
radicals [20–22]), and nitric oxide synthase (NOS, generates nitric
oxide [11]). We therefore pre-treated THP-1 cells with 250 mg/ml
allopurinol (XOD inhibitor) [20] or 100 mM N-monomethyl-
arginine (NOS inhibitor [10,12]) and exposed them to 100 ng/ml
SCF for 4 h. We found that allopurinol but not NMMA blocked
both SCF-induced HIF-1a accumulation and VEGF production
(Figure 5) suggesting that XOD but not NOS is involved in SCF-
mediated processes.
The PI3 kinase pathway is known to upregulate HIF-1a
accumulation in an mTOR-dependent manner [23,24]. The
Figure 2. The impact of SCF withdrawal on HIF-1a accumulation and the GSH-dependent antioxidative system in LAD2 human mast
cells. LAD2 cells (which were continuously cultured in the presence of 100 ng/ml SCF) were incubated in fresh media containing 100 ng/ml SCF for
24 h, while another fraction of these cells was subjected to SCF-free media for 24 h. (A) HIF-1a accumulation, GSH and GSSG levels, GPx/GR activities
and the quantity of the TBRS were then measured as outlined in Materials and methods. HIF-1 DNA-binding activity was also analysed. (B)
Quantitative data are mean values 6 S.D. of at least three individual experiments. *P,0.01 vs control. Western blot data are shown from one
representative experiment out of three that gave similar results.
doi:10.1371/journal.pone.0022502.g002
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kinase-related kinase protein family, contributes to regulation of
protein synthesis and also transcription, thus impacting cell
growth, proliferation, motility and survival [24,25]. SCF is known
to upregulate the delta isoform of PKC (PKC-d) [25], which has
also been shown to activate mTOR [26]. To address this question
we pre-treated THP-1 cells for 1 h with 100 mM rottlerin (PKC-d
inhibitor [12,25]) or 10 mM rapamycin (mTOR blocker) [23,24]
and then exposed them for 4 h to 100 ng/ml SCF. We found that
both rottlerin and rapamycin completely attenuated SCF-induced
HIF-1a accumulation and VEGF production in THP-1 cells
(Figure 5) suggesting that these two enzymes are crucial for SCF-
induced HIF-1a activation.
Finally, we investigated the impact of ASK1 (as a pro-apoptotic
negative regulator of protein synthesis), PKC-d and XOD on
mTOR accumulation and S2448 phosphorylation (XOD contrib-
utes to a crucial step of purine nucleotide catabolism, possibly
influencing biochemical events associated with the whole transcrip-
tion/translation system). In these experiments we pre-treated THP-
1 cells with 10 mM rapamycin, 100 mM rottlerin or 250 mg/ml
allopurinol for 1 h followed by 4 h of exposure to 100 ng/ml SCF.
Some of the THP-1 cells were also transfected with the dominant-
negative isoform of ASK1 and then exposed for 4 h to 100 ng/ml
SCF. The accumulation of mTOR and HIF-1a protein were then
analysed. We found that SCF clearly upregulated mTOR
accumulation/S2448 phosphorylation in THP-1 cells. These proce-
sses were attenuated by rapamycin, rottlerin and allopurinol show-
ing that both PKC-d and XOD contribute to SCF-induced mTOR
activation (Figure 6). Downregulation of ASK1 induced by its
dominant-negative form led to a further non-significant increase in
intracellular mTOR and its S2448 phosphorylation levels in THP-1
cells exposed to SCF. The effects of the above agents on the mTOR
accumulation/S2448-phosphorylation correlated with those ob-
served for HIF-1a (Figure 6). Interestingly, in LAD2 cells, mTOR
was constitutively expressed and phosphorylated when they were
cultured in the presence of 100 ng/ml SCF or kept for 24 h in the
absence of this cytokine, which is consistent with absence in changes
in HIF-1a accumulation (Figure 6).
Discussion
SCF is recognised as a hematopoietic growth factor that exerts
its activity by signalling through the type III receptor tyrosine
kinase known as Kit receptor or CD117 [1]. SCF-Kit signalling is
Figure 3. GSH depletion leads to a reduction of SCF-induced HIF-1a PHD activity in THP-1 cells. THP-1 human myeloid leukaemia cells
were cultured (in fresh medium) for 24 h in the absence or presence of 100 ng/ml SCF 6 500 mM BSO. (A) HIF-1a accumulation/PHD activity and (B)
annexin V/DAPI staining were performed as outlined in Materials and methods. Quantitative data are mean values 6 S.D. of at least three individual
experiments. *P,0.01 vs control. All Western blot and imaging data are from one representative experiment out of three that gave similar results.
doi:10.1371/journal.pone.0022502.g003
Figure 4. GSH depletion leads to a strong decrease in SCF-dependent HIF-1a PHD activity in LAD2 cells. LAD2 cells were incubated for
24 h in fresh media 6100 ng/ml SCF and 6500 mM BSO. (A) HIF-1a accumulation and PHD activity were assessed as well as (B) Annexin V and DAPI
staining as outlined in Materials and methods. Western blot and imaging data are from one representative experiment out of three. Quantitative data
are mean values 6 S.D. of at least three individual experiments. *P,0.01 vs control.
doi:10.1371/journal.pone.0022502.g004
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poietic cells of myeloid lineage [1]. Since myeloid leukaemia cells
express the Kit receptor and are sensitive to SCF, this tyrosine
kinase pathway has been suggested to contribute to leukaemia
progression [1,2], although, the molecular mechanisms of this
pathophysiological SCF-Kit function remain unclear. SCF is also
crucial for functioning of mast cells, which are the only terminally
differentiated hematopoietic cells that express Kit receptors
[1,3,4]. Recent evidence demonstrated that SCF induces accu-
mulation of the inducible alpha subunit of HIF-1 transcription
complex which limits its biological activity [5]. HIF-1 is crucial for
cellular adaptation to low oxygen availability and angiogenesis,
which form an important part of myeloid leukaemia progression
[6,27]. Since SCF acts via MEK, PI3 kinase and, possibly, PKC a/
b isoforms, one could hypothesise that SCF as such impacts on the
activation of NADPH oxidase leading to ROS generation. This
event is known to reduce the activity of HIF-1a degrading PHDs
[10,13]. On the other hand, mast cells (for example LAD2) are
cultured in the presence of SCF since they require this factor in
principle [14]. But these cells are not known to suffer from
permanent oxidative stress. One could hypothesise that the ability
of SCF to induce the production of biochemically active ROS is
controlled by a glutathione-dependent anti-oxidative system. It
was, however, unknown how powerful this GSH antioxidative
system in myeloid leukaemia and mast cells is. In addition, it was
unclear whether this system, and redox-dependent mechanisms in
general play a role in SCF-induced HIF-1a accumulation or the
alternative mechanisms control the process.
To answer these questions we investigated whether SCF triggers
HIF-1a accumulation in THP-1 human myeloid cells and in LAD2
mast cells. We also studied how SCF-Kit signalling impacts on the
GSH-dependent antioxidative system and intracellular oxidative
stress. Exposure of THP-1 cells to 100 ng/ml SCF significantly
increased HIF-1a accumulation. This correlated with a decreased
level of intracellular GSH and decreased GSH/GSSG ratio. GPx
activity was also reduced with no significant changes in GR activity
(see Figures 1A for details) indicating that the GSH-dependent
system is affected in THP-1 cells under the influence of SCF. This
conclusion was further supported by the observed SCF-dependent
moderate increase in TBRS (Figure 1A). Removal of SCF from
LAD2mast cell cultures did not result in significant changes in HIF-
1a accumulation compared to cells cultured in the normal manner
with 100 ng/ml of the cytokine. However, this does not necessarily
prove that SCF does not induce HIF-1a accumulation in LAD2
cells. Rather, the constitutive accumulation of HIF-1a could be
close to the necessary functional threshold where any additional
stimulation with SCF does not significantly increase its levels.
Intracellular GSH levels and GSH/GSSG ratio were significantly
higher when the SCF was present. The increase in GSH/GSSG
ratio was, however, lower compared to the elevation of GSH,
suggesting that GSSG levels also rose. GPxactivity was reduced and
GR activity was not affected. This suggests that LAD2 cells are by
upregulating glutathione production in the presence of SCF (see
Figure 2A). This effect in principle applies to both cell types (THP-1
and LAD2) since the amount of total glutathione (GSH+GSSG) was
increased by SCF in both cases (321638 % control in LAD2 cells
and 182617 % control in THP-1 cells). This might even permit the
useofGSHasadirectROSscavengerwithout employingtheGSH-
dependent enzymes in these cells. In LAD2 cells exposed to SCF,
TBRS levels were not changed compared to cells cultured in the
Figure 5. Signalling pathways involved in SCF-induced HIF-1a accumulation in THP-1 human myeloid leukaemia cells. THP-1 cells
were pre-treated for one hour with the indicated concentrations of the outlined inhibitors. In one case cells were transfected with dominant-negative
form of ASK1 (ASK1-KM) as indicated in Materials and methods. After that THP-1 cells were exposed for 4 h to 100 ng/ml SCF followed by Western
blot analysis of HIF-1a accumulation and ELISA assay of the VEGF release. Quantitative data are mean values 6 S.D. of at least three individual
experiments. *P,0.01 vs control.
a – differences are significant when comparing two indicated values (P,0.01). All Western blot data are from one
experiment representative of three that gave similar results.
doi:10.1371/journal.pone.0022502.g005
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active (Figures 1B and 2B). We also found that in THP-1 cells SCF-
induced HIF-1a accumulation is a concentration-dependent
process (see Figure 1C). It is important to mention that a high
level of basic HIF-1a accumulation in LAD2 mast cells was
observed independently of the presence of SCF. This is possibly a
result of a high level of glycolysis in these cells [28,29]. HIF-1 is
known to control glycolysis on the transcriptional level [27], with
ATP produced via glycolysis and thereby playing a crucial role in
mast cell function [28].
We therefore investigated the role of GSH in regulation of HIF-
1a accumulation and PHD activity in both THP-1 and LAD2
cells. Cells were exposed to 500 mM BSO in the absence or
presence of 100 ng/ml SCF. In THP-1 cells we observed a
reduction of PHD activity in the BSO treated cells in the absence
of SCF. HIF-1a accumulation was non-significantly decreased,
which is probably a result of the fact that some of the BSO treated
cells underwent apoptotic changes (Figure 3A and B). In the
presence of SCF, BSO led to a strong reduction in PHD activity.
However, SCF-induced HIF-1a accumulation was not affected,
while the numbers of apoptotic cells were increased compared to
experiments when the cells were exposed to SCF in the absence of
BSO (see Figure 3A and B). Similar effects were observed in LAD2
cells but differed in that SCF did not lead to a significant increase
in HIF-1a accumulation. Furthermore, BSO induced apoptosis of
a higher number of LAD2 cells and in the presence of both BSO
and SCF, PHD activity was substantially attenuated (Figure 4A
and B). One could therefore assume that the GSH-dependent
system is more powerful in LAD2 mast cells compared to that of
THP-1 myeloid leukaemia cells. BSO-induced reduction in PHD
activity, especially in the presence of SCF, might be a compensa-
tory mechanism which supports the generation of the required
level of HIF-1a in these cells. Alternatively, oxidation of the PHD
catalytic site may also lead to a steady level of HIF-1a. However, it
is important to mention that the decrease in PHD activity induced
by SCF was minor especially in LAD2 cells (see Figures 3A and 4
A). This suggests a minor contribution of PHD to SCF-induced
HIF-1a accumulation.
Mechanistic experiments using pharmacological inhibitors of a
number of signalling enzymes suggested that ERK is involved in
SCF-induced HIF-1a accumulation/activation in THP-1 cells.
While PLC-1c did not seem to affect the process, the PKC a/b-
NADPH oxidase-ROS branch was found to contribute to the
SCF-dependent HIF-1a accumulation and activation (given the
respective values of released VEGF). However, this contribution
was moderate compared to the role of other pathways. A crucial
role for PI3 kinase, PKC-d and mTOR was observed. PI3 kinase
and also PKC-d are known to be activated in SCF-dependent
manner [1,5,25,26]. Both pathways appear to activate mTOR and
blocking mTOR with rapamycin or inhibition of any of these
kinases – PI3 kinase or PKC-d strongly attenuated SCF-induced
HIF-1a accumulation in THP-1 cells (Figure 5).
Figure 6. Several pathways impact SCF-dependent HIF-1a accumulation via mTOR in THP-1 human myeloid cells. THP-1 cells were pre-
treated for one hour with the indicated concentrations of the outlined inhibitors. In one case cells were transfected with dominant-negative form of
ASK1 (ASK1-KM) as indicated in Materials and methods. THP-1 cells were then exposed for 4 h to 100 ng/ml SCF followed by Western blot analysis of
HIF-1a and mTOR accumulation as well as S2448 phosphorylation. LAD2 cells were cultured for 24 h in the absence or presence of 100 ng/ml SCF. All
Western blot data are from one experiment representative of three that gave similar results. Quantitative data are mean values 6 S.D. of at least three
individual experiments. *P,0.01 vs control.
a – differences are significant when comparing two indicated values (P,0.01).
doi:10.1371/journal.pone.0022502.g006
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a NOS inhibitor, also decreased SCF-induced HIF-1a accumu-
lation. Attenuation of ASK1 activity by transfection of THP-1 cells
with dominant-negative ASK1 isoform led to a further increase in
SCF-induced HIF-1a accumulation (Figure 5).
mTOR was found crucial for SCF-induced HIF-1a accumula-
tion in THP-1 cells, which actually confirmed previous observa-
tions suggesting translational nature of SCF-induced HIF-1a
activation [5]. We therefore investigated whether the most effecti-
ve inhibitors are able to affect mTOR as well as its S2448
phosphorylation and found that levels of accumulated HIF-1a and
mTOR/phospho-S2448-mTOR correlated (see Figure 6). Rapa-
mycin and rottlerin (PKC-d inhibitor) led to attenuation of SCF-
induced mTOR/phospho-S2448-mTOR levels; the same effect
was also observed for the XOD inhibitor (Figure 6). Since XOD
contributes to a crucial step of purine nucleotide catabolism
controlling their utilisation and re-use, it might influence
biochemical events associated with the whole transcription/
translation system. Downregulation of ASK1 activity achieved
by transfection of the cells with its dominant-negative isoform led
to a further non-significant increase in mTOR/phospho-S2448-
mTOR levels, which correlated with the effect observed on HIF-
1a accumulation (see Figure 6). Such an effect could be possibly
explained by the pro-apoptotic nature of the redox-dependent
ASK1 activity in the cells [30]. The lack of significant differences
in this case could also be a result of the respective protein levels
reaching the thresholds required for their specific functions.
Interestingly, in LAD2 cells, mTOR was constitutively expressed
and phosphorylated when the cells were cultured either in the
presence of 100 ng/ml SCF or kept for 24 h in the absence of this
cytokine. These observations are consistent with a previously
published observation [31] as well as the absence of changes in
HIF-1a accumulation seen in the present study (see Figure 6).
We conclude that SCF leads to a significant accumulation/
activation of HIF-1a in human myeloid leukaemia THP-1 cells
but not in LAD2 human mast cells. LAD2 cells employ a more
powerful GSH-dependent antioxidative system compared to THP-
1 myeloid leukaemia cells. LAD2 mast cells are therefore
completely protected against action of ROS generated in SCF-
mediated manner. In both cases GSH plays an ROS scavenging
role. BSO-induced GSH depletion leads to a significant decrease
in PHD activity in THP-1 cells and to near attenuation of it in
LAD2 cells. In THP-1 cells SCF-induced HIF-1a accumulation is
controlled via ERK, PI3 kinase/PKC-d/mTOR-dependent and to
certain extent by a redox-dependent mechanisms. Additionally,
XOD contributes to SCF-induced mTOR accumulation, while it
is also known to produce superoxide anion-radicals. These
mechanisms are summarised in the scheme presented in the
Figure 7.
In summary, our results demonstrate the mechanisms involved
in SCF-induced HIF-1 activation in human myeloid leukaemia
cells. HIF-1 is crucial for cellular adaptation to low oxygen
availability [27] and hypoxia is a physiological environment for
cancer progression including myeloid leukaemia [6,27]. Given
this, our results demonstrate for the first time an important cross-
talk of signalling pathways associated with this crucial stage in the
myeloid leukaemia cell life cycle.
Materials and Methods
Materials
RPMI-1640 medium, foetal calf serum and supplements,
DOTAP transfection reagent, GSH, GSSG and BSO were
purchased from Sigma (Suffolk, UK). Maxisorp
TM microtitre
plates were obtained from Nunc (Roskilde, Denmark). ELISA-
based assay kit for detection of VEGF was bought from R&D
Systems (Abingdon, UK). Mouse monoclonal antibodies to HIF-
1a, mTOR and b-actin as well as rabbit polyclonal antibody
against phospho-S2448 mTOR were from Abcam (Cambridge,
UK). Goat anti-mouse and goat anti-rabbit fluorescence dye-
labelled antibodies were obtained from Li-Cor (Lincoln, Nebraska
USA). Stem-Pro-34 serum-free media and SCF were obtained
from Invitrogen (Paisley, UK). Biotinylated peptide (biotin-
DLDLEMLAPYIPMDDDFQL – the peptide corresponds to the
region of HIF-1a protein which is between 556
th and 574
th amino
acid residues) – the substrate of HIF-1a PHD was obtained from
Biopeptide Co. (San Diego, CA, USA). All other chemicals were of
the highest grade of purity and commercially available.
LAD2 mast cells
LAD2 mast cells were kindly provided by A. Kirshenbaum and
D. Metcalfe (NIH, USA). Cells were cultured in the Stem-Pro-34
serum-free media with supplement containing 2 mM L-glutamine,
penicillin (100 units/ml), streptomycin (100 mg/ml) and recombi-
nant human SCF (100 ng/ml) [14].
THP-1 human myeloid cells
THP-1 human leukaemia monocytic macrophages were
purchased from the European collection of Cell Cultures (Salis-
bury, UK). Cells were grown in RPMI 1640 media supplemented
with 10% foetal calf serum, penicillin (50 IU/ml) and streptomy-
cin sulphate (50 mg/ml).
Plasmids
Plasmid encoding hemagglutinin (HA)-tagged human ASK1
with kinase-dead domain (dominant-negative form, ASK1-KM)
was a kind gift of Professor H. Ichijo (University of Tokyo, Tokyo,
Japan). Plasmid was amplified in E. Coli XL10 GoldH (Stratagene
Europe, Amsterdam, The Netherlands) and purified using
GenElute
TM plasmid purification kit according to the manufac-
turer’s protocol. Purified plasmids were transfected into THP-1
cells using DOTAP transfection reagent according to the
manufacturer’s protocol. Successful transfection was monitored
by Western blot [10,30] (360.6 fold of increase in ASK1 was
observed in the transfected cells) and detection of its kinase activity
[10,30], which was attenuated in all experiments – as shown in our
previous reports [10,30].
Western blot analysis
HIF-1amTOR and phospho-S2448mTORweredeterminedby
Western blot analysis, as previously described [10,12]. Briefly, cells
were incubated for the times indicated, washed twice with ice-cold
phosphate-buffered saline (PBS) and lysed in 200 ml of lysis buffer
(50 mM Tris–HCl, 5 mM EDTA, 150 mM NaCl, 0.5% Nonidet-
40, 1 mM PMSF, pH 8.0). After centrifugation (13000 rpm,
15 min) the protein content in the supernatants was analysed.
Finally, 40 mg of protein was added to the same volume of 26
sample buffer (125 mM Tris–HCl, 2% sodium dodecyl sulfate
(SDS), 10% glycerine, 1 mM dithiothreitol (DTT), 0.002%
bromphenol blue, pH 6.9) and boiled for 5 min. Proteins were
resolved on 7.5% SDS–polyacrylamide gels and blotted to
nitrocellulose membranes. Molecular weights were calibrated in
proportion to the running distance of rainbow markers. HIF-1 or
mTOR antibodies were added and incubated for 60 min at room
temperature. Afterwards, nitrocellulose membranes were washed
five times for 15 min and subjected to incubation with Li-Cor
(Lincoln, Nebraska USA) goat secondary antibodies conjugated
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protocol. b-actin staining was used to confirm equal protein loading
as described previously. The Western blot data for HIF-1a protein
weresubjected toa quantitative analysisusingOdysseysoftwareand
values were normalised against respective actin bands.
Determination of HIF-1 DNA-binding activity
HIF-1 DNA-binding activity was measured by the method
similar to the one described recently [10,12]. A 96-well maxisorp
TM
microtitre plate was coated with streptavidin and blocked with BSA.
2 pmol/well biotinylated 2HRE-containing oligonucleotide were
immobilised by 1 h incubation at room temperature. The plate was
then washed 5 times with TBST buffer (10 mM Tris-HCl, pH 8.0,
150 mM NaCl, 0.05% Tween-20) followed by 1 h incubation with
20 ml/well of cell lysate at room temperature. The plate was again
washed 5 times with TBST buffer and mouse anti-HIF-1a antibody
(1:1000 in TBS plus 2% BSA) was added. After 1 h of incubation at
room temperature the plate was washed 5 times with TBST buffer
and incubated with 1:1000 HRP-labelled rabbit anti-mouse IgG in
TBST buffer and, after extensive washing with TBST, the bound
secondary antibody was detected by the peroxidase reaction (ortho-
phenylenediamine/H2O2, Kem-En-Tek Diagnostics, Copenhagen,
Denmark). Reactions were quenched after 10 min with an equal
volume of 1 M H2SO4 and the colour development was measured
in a microplate reader (absorbance at 492 nm). DNA-binding
activity of HIF-1 was calculated as OD492 per mg protein present
in the cell lysates compared to 10 mg/ml BSA (negative control).
Measurement of VEGF production
Production of VEGF by the THP-1 cells was analysed by
ELISA according to the manufacturer’s protocols.
Analysis of HIF-1a PHD activity
To detect HIF-1a PHD activity we employed a peptide-based
assay as described before [13,32]. For the assay we used HIF-1a-
free cell lysates to avoid the impact of hydroxylation of the
intracellular HIF-1a. Lysates of non-treated and treated THP-1
cells were incubated for one hour in the 96-well maxisorp
TM
microtitre plates, which were coated with HIF-1a capture
antibody and blocked with BSA as described before [13]. Upon
completion of the incubation lysates were used for the PHD assay.
Peptide-based assay. A 96-well maxisorp
TM microtitre plate
was coated with streptavidin and blocked with BSA as described
before [13]. 100 ng/well of biotinylated peptide DLDLEMLAPYI-
PMDDDFQL was then immobilised as described. The plate was
washed 3 times with TBST buffer (10 mM Tris-HCl, pH 8.0,
150 mM NaCl, 0.05% Tween-20). Then HIF-1a-free cell lysates
(where the PHD activity was tested) wereadded to the wells together
with the 20 mM Tris PHD assay buffer (pH 7.5) containing also
5 mM KCl, 1.5 mM MgCL2,1 0 0mM 2-OG, 10 mM FeSO4 and
2 mM ascorbate in a final volume 120 ml. The plates were
incubated for 60 min at room temperature and the reaction was
stoppedbywashingtheplate 3timeswiththe TBSTbuffer.Wethen
measured the binding of pVHL to the peptide[13,32]. PHD activity
inthe non-treated THP-1 cellsnormalised againstthe amount of the
intracellular protein detected by Bradford assay was counted as 100
%. Respectively, the activity in other samples was expressed as %
control.
Glutathione determination
Cellswerelysedbytheadditionof150 ml 1%sulfosalicyl acid and
incubation for at least 10 min at 4uC. After centrifugation
(10,0006g, 5 min), 130 ml of the supernatant was further processed
for GSSG quantification. GSH content was directly measured. For
GSSG analysis, reduced glutathione was derivatised by the addition
of 5 ml 2-vinylpyridine for 1 h at room temperature. The amount of
GSSG in 50 or 40 ml of GSH lysate was measured according to the
method of Tietze, which is based on the reduction of 5,59-dithiobis-
(2-nitrobenzoic) acid (DTNB) (150 mM) [15,33].
Glutathione reductase and glutathione peroxidise
activity assays
Glutathione peroxidise and glutathione reductase activities were
analysed by spectrophotometric assays as described before [15,34].
Figure 7. Possible mechanisms of SCF-dependent HIF-1a accumulation in human myeloid leukaemia cells. Implication of a GSH-
dependent antioxidative system. The scheme demonstrates the involvement of ERK, PI3 kinase/PKC-d-mTOR, PKC a/b-NADPH oxidase-ROS and
XOD pathways in SCF-induced Kit receptor-dependent HIF-1a accumulation in THP-1 human myeloid leukaemia cells. The implication of GSH-
dependent antioxidative system and ASK1 in the process is outlined.
doi:10.1371/journal.pone.0022502.g007
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TBRS were detected using colorimetric assay as indicated
before [35].
Annexin V and DAPI stainings
Cells undergoing apoptosis were detected using Annexin V
staining. VybrantH apoptosis assay kit (Invitrogen, Paisley, UK)
containing Annexin V conjugated with Alexa Fluor 488 was used
for this analysis according to the manufacturer’s protocol. 49,6-
diamidino-2-phenylindole diactate (DAPI, Invitrogen, Paisley,
UK) staining was used according to the manufacturer’s protocol
to assess the total amount of cells. Fluorescent microscope (Nikon
Eclipse 50i) was employed for visualisation and the images were
captured using Image Pro Plus software.
Statistical analysis
Each experiment was performed at least three times and
statistical analysis was conducted using two-tailed Student’s t test.
Statistical probabilities (P) were expressed as *, where P,0.01.
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